BDTX
Price
$4.47
Change
-$0.40 (-8.21%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
255.25M
124 days until earnings call
Intraday BUY SELL Signals
CGEM
Price
$8.27
Change
-$0.08 (-0.96%)
Updated
Nov 13 closing price
Capitalization
489.15M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDTX vs CGEM

Header iconBDTX vs CGEM Comparison
Open Charts BDTX vs CGEMBanner chart's image
Black Diamond Therapeutics
Price$4.47
Change-$0.40 (-8.21%)
Volume$19.18K
Capitalization255.25M
Cullinan Therapeutics
Price$8.27
Change-$0.08 (-0.96%)
Volume$649K
Capitalization489.15M
BDTX vs CGEM Comparison Chart in %
BDTX
Daily Signal:
Gain/Loss:
CGEM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BDTX vs. CGEM commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Buy and CGEM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BDTX: $4.87 vs. CGEM: $8.35)
Brand notoriety: BDTX and CGEM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 151% vs. CGEM: 66%
Market capitalization -- BDTX: $255.25M vs. CGEM: $489.15M
BDTX [@Biotechnology] is valued at $255.25M. CGEM’s [@Biotechnology] market capitalization is $489.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green whileCGEM’s FA Score has 1 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • CGEM’s FA Score: 1 green, 4 red.
According to our system of comparison, both BDTX and CGEM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 4 TA indicator(s) are bullish while CGEM’s TA Score has 5 bullish TA indicator(s).

  • BDTX’s TA Score: 4 bullish, 4 bearish.
  • CGEM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BDTX and CGEM are a good buy in the short-term.

Price Growth

BDTX (@Biotechnology) experienced а +25.84% price change this week, while CGEM (@Biotechnology) price change was +14.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

BDTX is expected to report earnings on Mar 18, 2026.

CGEM is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($489M) has a higher market cap than BDTX($255M). BDTX YTD gains are higher at: 127.570 vs. CGEM (-31.445). BDTX has higher annual earnings (EBITDA): 5.05M vs. CGEM (-234.39M). CGEM has more cash in the bank: 265M vs. BDTX (143M). CGEM has less debt than BDTX: CGEM (1.52M) vs BDTX (20.8M). BDTX has higher revenues than CGEM: BDTX (70M) vs CGEM (0).
BDTXCGEMBDTX / CGEM
Capitalization255M489M52%
EBITDA5.05M-234.39M-2%
Gain YTD127.570-31.445-406%
P/E Ratio12.11N/A-
Revenue70M0-
Total Cash143M265M54%
Total Debt20.8M1.52M1,369%
TECHNICAL ANALYSIS
Technical Analysis
BDTXCGEM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 23 days ago
89%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signal:
Gain/Loss:
CGEM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TPCIX34.710.68
+2.00%
Timothy Plan Israel Common Values C
CAFRX11.260.21
+1.90%
Commonwealth Africa
ASCLX13.970.03
+0.22%
AB Select US Long/Short C
PRNIX29.800.06
+0.20%
Virtus NFJ Mid-Cap Value Inst
JMCEX64.000.05
+0.08%
JPMorgan Mid Cap Equity R2

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with RLAY. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
+5.41%
RLAY - BDTX
55%
Loosely correlated
-1.91%
NRIX - BDTX
49%
Loosely correlated
-5.37%
VYGR - BDTX
49%
Loosely correlated
-0.23%
CRBU - BDTX
48%
Loosely correlated
+0.89%
CGEM - BDTX
47%
Loosely correlated
+7.05%
More

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with IDYA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
+7.05%
IDYA - CGEM
49%
Loosely correlated
-0.19%
BDTX - CGEM
47%
Loosely correlated
+5.41%
AURA - CGEM
47%
Loosely correlated
-1.59%
DNLI - CGEM
47%
Loosely correlated
-0.34%
TRDA - CGEM
46%
Loosely correlated
+4.03%
More